Robert Desnick

Search results

• Research on Erythropoietic Protoporphyria Described by Researchers at Icahn School of Medicine at Mount Sinai (A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria)

  Jessica Overbey, Manisha Balwani, Hetanshi Naik & Robert Desnick

  14/12/22

  1 item of Media coverage

  Press/Media

• Mount Sinai's Yvette Calderon, MD, MS, Elected To National Academy Of Medicine For Contributions To Emergency Medicine

  Eric Nestler, Lynne Richardson, Yvette Calderon, Rachel Yehuda, Ramon Parsons, Brendan Carr, Peter Palese, Neil Calman, Alison Goate, Albert Siu, Helen Mayberg,, Joseph Buxbaum, Bruce Gelb, Yasmin Hurd, Robert Desnick, Kenneth L. Davis, Kurt Hirschhorn, Hugh Sampson & Diane Meier

  20/10/22

  1 item of Media coverage

  Press/Media

• Mount Sinai’s Yvette Calderon, MD, MS, Elected to National Academy of Medicine for Contributions to Emergency Medicine

  Eric Nestler, Lynne Richardson, Yvette Calderon, Rachel Yehuda, Ramon Parsons, Brendan Carr, Peter Palese, Neil Calman, Alison Goate, Albert Siu, Helen Mayberg,, Joseph Buxbaum, Bruce Gelb, Yasmin Hurd, Robert Desnick, Kenneth L. Davis, Kurt Hirschhorn, Hugh Sampson & Diane Meier

  19/10/22

  4 items of Media coverage

  Press/Media

• US Patent Issued to Icahn School of Medicine at Mount Sinai on March 22 for "Materials and methods for identifying spinal muscular atrophy carriers" (New York Inventors)

  Lisa Edelmann & Robert Desnick

  22/03/22

  1 item of Media coverage

  Press/Media

• Rep. Castor Issues Statement Honoring 175 Inventors Inducted As 2020 Fellows of The National Academy of Inventors

  Edward Schuchman & Robert Desnick

  26/06/21

  1 item of Media coverage

  Press/Media

• U.S. Patents Awarded to Inventors in New York (June 12)

  Makiko Yasuda, Robert Desnick & Wei Zheng

  12/06/21

  2 items of Media coverage

  Press/Media

• Alnylam Pharmaceuticals, ICAHN School of Medicine at Mount Sinai Assigned Patent for inhibiting expression of the ALAS1 gene

  Makiko Yasuda & Robert Desnick

  12/06/21

  1 item of Media coverage

  Press/Media

• US Patent Issued to Alnylam Pharmaceuticals, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI on June 8 for "Compositions and methods for inhibiting expression of the ALAS1 gene" (Massachusetts, New York Inventors)

  Makiko Yasuda & Robert Desnick

  9/06/21

  1 item of Media coverage

  Press/Media

• Recordati : THE TENTH EDITION OF THE ARRIGO RECORDATI INTERNATIONAL PRIZE FOR SCIENTIFIC RESEARCH HAS ANNOUNCED THE CALL FOR APPLICATIONS

  Robert Desnick

  25/05/21

  1 item of Media coverage

  Press/Media

• Australian Patent Office Grants Patent for 'Compositions and methods for inhibiting expression of the ALAS1 gene'

  Makiko Yasuda & Robert Desnick

  7/05/21

  1 item of Media coverage

  Press/Media

• Long-term data on Fabrazyme® (agalsidase beta) for people with Fabry disease

  Robert Desnick

  12/03/21

  1 item of Media coverage

  Press/Media

• INVENTORS ACADEMY NAMES FELLOWS; RYLAARSDAM IS NEW BETHEL PROVOST

  Robert Desnick

  25/01/21

  1 item of Media coverage

  Press/Media

• Inventors academy names fellows; Rylaarsdam is new Bethel provost

  Robert Desnick

  25/01/21

  1 item of Media coverage

  Press/Media

• Australia Patent: Alnylam Pharmaceuticals, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI File Application for 'Compositions and methods for inhibiting expression of the ALAS1 gene'

  Makiko Yasuda & Robert Desnick

  15/01/21

  1 item of Media coverage

  Press/Media

• Australia: Icahn School of Medicine at Mount Sinai, Alnylam Pharmaceuticals Receive Patent for 'Compositions and methods for inhibiting expression of the ALAS1 gene'

  Makiko Yasuda & Robert Desnick

  8/01/21

  1 item of Media coverage

  Press/Media

• Order and chaos

  Robert Desnick

  16/11/20

  1 item of Media coverage

  Press/Media

• Australian Patent Office Grants Patent for 'DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY'

  Robert Desnick

  13/11/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Genzyme, Icahn School of Medicine at Mount Sinai File Application for 'DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY'

  Robert Desnick

  6/11/20

  1 item of Media coverage

  Press/Media

• Photo Flash: New York Living Landmarks Celebration Goes Virtual for 2020

  Robert Desnick

  3/11/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Doctors Elected to National Academy of Medicine for Contributions to Emergency Medicine and Translational Genetics

  Eric Nestler, Lynne Richardson, Ramon Parsons,, Brendan Carr, Neil Calman, Joseph Buxbaum, Bruce Gelb, Yasmin Hurd, Rachel Yehuda, Albert Siu, Alison Goate, Peter Palese, Helen Mayberg,, Robert Desnick, Kenneth L. Davis, Kurt Hirschhorn, Hugh Sampson & Diane Meier

  19/10/20

  3 items of Media coverage

  Press/Media

• Australian Patent Office Grants Patent for 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE'

  Makiko Yasuda & Robert Desnick

  11/09/20

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Dean Issues Public Comment on Centers for Medicare & Medicaid Services Proposed Rule

  Robert Desnick

  21/07/20

  1 item of Media coverage

  Press/Media

• American Porphyria Foundation Issues Public Comment on Centers for Medicare & Medicaid Services Proposed Rule

  Robert Desnick

  19/07/20

  1 item of Media coverage

  Press/Media

• Australia: Genzyme, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Receive Patent for 'DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY'

  Robert Desnick

  17/07/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Alnylam Pharmaceuticals, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI File Application for 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE'

  Makiko Yasuda & Robert Desnick

  19/05/18 → 23/05/20

  2 items of Media coverage

  Press/Media